We hypothesize that the therapeutic effect of AAV9‐PKP2 may involve regulating the interaction between CD45 and CD22, thereby interfering with fibrosis formation post‐HF through CCDC80 and APOE. Here, CCDC80 is linked to hydrops fetalis.